Skip to main content

Generation of tolerogenic dendritic cells via the E-cadherin/β-catenin-signaling pathway

Immunologic Research volume 46, pages 72–78 (2010)Cite this article

Abstract

Besides their well-characterized role as the initiator of adaptive immune responses, dendritic cells (DCs) play a critical role in the induction and maintenance of self-tolerance, the failure of which could lead to autoimmune/inflammatory diseases. Although it is clear that tolerance is a property of DCs at the steady state, the molecular mechanisms governing their generation, function and regulation remain elusive. Our recent studies have uncovered the E-cadherin/β-catenin-signaling pathway as a novel maturation pathway that achieves DC maturation without inflammatory cytokines. As a result, E-cadherin-stimulated DCs elicited an entirely different T cell response in vivo, generating T cells with a regulatory as opposed to an effector phenotype. These DCs induced tolerance in vivo and more importantly, immunization with these DCs provided complete protection against autoimmune diseases in experimental autoimmune encephalomyelitis (EAE). Interestingly, while DCs matured upon disruption of E-cadherin-mediated clusters were functional tolerogenic, upon further TLR ligation, they displayed a strong Th1 cytokine profile and much enhanced antigen presentation capacity consistent with enhanced immunity. Thus, E-cadherin/β-catenin-signaling might serve as a novel signal that contributes to the elusive steady-state “tolerogenic DCs”. Targeting E-cadherin/β-catenin signaling to either enhance or reduce DC-mediated tolerance might represent an attractive new strategy to achieve antigen-specific immunotherapy for cancers and autoimmune/inflammatory diseases.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–52.

    Article  PubMed  CAS  Google Scholar 

  2. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711.

    Article  PubMed  CAS  Google Scholar 

  3. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell. 2001;106:255–8.

    Article  PubMed  CAS  Google Scholar 

  4. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005;23:975–1028.

    Article  PubMed  CAS  Google Scholar 

  5. Randolph GJ, Sanchez-Schmitz G, Angeli V. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin Immunopathol. 2005;26:273–87.

    Article  PubMed  Google Scholar 

  6. Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol. 2001;2:487–92.

    Article  PubMed  CAS  Google Scholar 

  7. Geissmann F, Dieu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M, et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med. 2002;196:417–30.

    Article  PubMed  CAS  Google Scholar 

  8. Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O, et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med. 2002;196:1553–61.

    Article  PubMed  CAS  Google Scholar 

  9. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol. 2001;166:5688–94.

    PubMed  CAS  Google Scholar 

  10. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity. 2004;21:733–41.

    Article  PubMed  CAS  Google Scholar 

  11. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000;191:411–6.

    Article  PubMed  CAS  Google Scholar 

  12. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006;6:476–83.

    Article  PubMed  CAS  Google Scholar 

  13. Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 2000;288:522–7.

    Article  PubMed  CAS  Google Scholar 

  14. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C, et al. The formation of immunogenic major histocompatibility complex class II- peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med. 2000;191:927–36.

    Article  PubMed  CAS  Google Scholar 

  15. Benvenuti F, Hugues S, Walmsley M, Ruf S, Fetler L, Popoff M, et al. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science. 2004;305:1150–3.

    Article  PubMed  CAS  Google Scholar 

  16. Benvenuti F, Lagaudriere-Gesbert C, Grandjean I, Jancic C, Hivroz C, Trautmann A, et al. Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol. 2004;172:292–301.

    PubMed  CAS  Google Scholar 

  17. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769–79.

    Article  PubMed  CAS  Google Scholar 

  18. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 2002;196:1627–38.

    Article  PubMed  CAS  Google Scholar 

  19. Hawiger D, Masilamani RF, Bettelli E, Kuchroo VK, Nussenzweig MC. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity. 2004;20:695–705.

    Article  PubMed  CAS  Google Scholar 

  20. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E- cadherin. Nature. 1993;361:82–5.

    Article  PubMed  CAS  Google Scholar 

  21. Jakob T, Udey MC. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol. 1998;160:4067–73.

    PubMed  CAS  Google Scholar 

  22. Jakob T, Brown MJ, Udey MC. Characterization of E-cadherin-containing junctions involving skin- derived dendritic cells. J Invest Dermatol. 1999;112:102–8.

    Article  PubMed  CAS  Google Scholar 

  23. Jakob T, Ring J, Udey MC. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol. 2001;108:688–96.

    Article  PubMed  CAS  Google Scholar 

  24. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol. 2002;3:1135–41.

    Article  PubMed  CAS  Google Scholar 

  25. Vasioukhin V, Fuchs E. Actin dynamics and cell–cell adhesion in epithelia. Curr Opin Cell Biol. 2001;13:76–84.

    Article  PubMed  CAS  Google Scholar 

  26. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483–7.

    Article  PubMed  CAS  Google Scholar 

  27. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol. 2005;5:21–30.

    Article  PubMed  CAS  Google Scholar 

  28. Riedl E, Stockl J, Majdic O, Scheinecker C, Rappersberger K, Knapp W, et al. Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells. J Immunol. 2000;165:1381–6.

    PubMed  CAS  Google Scholar 

  29. Riedl E, Stockl J, Majdic O, Scheinecker C, Knapp W, Strobl H. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood. 2000;96:4276–84.

    PubMed  CAS  Google Scholar 

  30. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S, et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity. 2007;27:610–24.

    Article  PubMed  CAS  Google Scholar 

  31. Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev. 2002;115:53–62.

    Article  PubMed  CAS  Google Scholar 

  32. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001;128:1253–64.

    PubMed  CAS  Google Scholar 

  33. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 1999;18:5931–42.

    Article  PubMed  CAS  Google Scholar 

  34. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature. 2007;449:361–5.

    Article  PubMed  CAS  Google Scholar 

  35. Tarner IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, et al. Treatment of autoimmune disease by adoptive cellular gene therapy. Ann N Y Acad Sci. 2003;998:512–9.

    Article  PubMed  CAS  Google Scholar 

  36. van Duivenvoorde LM, van Mierlo GJ, Boonman ZF, Toes RE. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology. 2006;211:627–32.

    Article  PubMed  CAS  Google Scholar 

  37. Palucka AK, Ueno H, Fay JW, Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol Rev. 2007;220:129–50.

    Article  PubMed  CAS  Google Scholar 

  38. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419–26.

    Article  PubMed  CAS  Google Scholar 

  39. Meijer L, Flajolet M, Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci. 2004;25:471–80.

    Article  PubMed  CAS  Google Scholar 

  40. Takemaru KI, Ohmitsu M, Li FQ. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics. Handb Exp Pharmacol. 2008;26:1–284.

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263, USA

    Chunmei Fu & Aimin Jiang

Authors
  1. Chunmei Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aimin Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aimin Jiang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fu, C., Jiang, A. Generation of tolerogenic dendritic cells via the E-cadherin/β-catenin-signaling pathway. Immunol Res 46, 72–78 (2010). https://doi.org/10.1007/s12026-009-8126-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-009-8126-5

Keywords

  • E-Cadherin
  • β-Catenin
  • DC maturation
  • Tolerance
  • Inflammatory cytokines
  • IL-10
  • Regulatory T cells